Opportunities Expanding Use in Obesity Management The growing use of GLP-1 analogues for the treatment of obesity is one of the largest opportunities
GLP-1 RAs stimulate the pancreas to create more insulin, a hormone that essentially gobbles up the glucose in your blood.12 That extra insulin leads to a reduction and balancing of blood sugar, which allows your body to more effectively regulate its fat stores without creating new, excessive adipose tissue
The introduction of highly efficacious and generally safe medications for obesity treatment, such as GLP-1RAs, has disrupted this framework, reframing obesity as a medical issue that can be treated pharmacologically
HDL cholesterol, often called good cholesterol, typically increases during weight loss and metabolic improvement
Additionally, investments are being made by governments and healthcare providers in diabetes awareness programs and access to treatment
"The Noom Microdose GLP-1Rx Program was designed to address this issue by introducing GLP-1s gradually and sustaining them at a microdose level, as part of a larger holistic behavior change platform, which we call our GLP-1 Companion
